Caenorhabditis elegans killing assay as an infection model to study the role of type III secretion in Burkholderia cenocepacia
The Burkholderia cepacia complex (BCC) consists of a group of related genospecies that include important opportunistic pathogens, especially in relation to cystic fibrosis (CF) (Mahenthiralingam et al., 2005) . The most common and pathogenically important member of the BCC is Burkholderia cenocepacia, which along with Burkholderia multivorans accounts for the vast majority of BCC isolates from CF patients.
Type III secretion (TTS) systems are implicated in the pathogenicity of a number of Gram-negative bacterial pathogens (Winstanley & Hart, 2001 ). Previously we cloned and sequenced the TTS gene cluster from B. cenocepacia ET12 lineage strain J2315 (GenBank AY028431). Furthermore we identified and sequenced TTS gene regions for strains representing genomovar I (B. cepacia) and B. multivorans (strain E243). Whilst genomovar I lacks TTS structural genes, it contains flanking genes, suggesting that a deletion has occurred. B. multivorans contains a gene cluster equivalent to that of B. cenocepacia J2315 (Glendinning et al., 2004) . It has been demonstrated that a TTS mutant of B. cenocepacia J2315 is attenuated for virulence in a murine model of infection (Tomich et al., 2003) , suggesting a role for TTS in pathogenicity. However, the precise role of TTS remains unclear, and the secreted effectors themselves have yet to be identified.
The Caenorhabditis elegans infection model has been used extensively to study bacterial virulence and host-pathogen interactions (Sifri et al., 2005; Alegado et al., 2003) . The model has been tested with various members of the BCC (Cardona et al., 2005) , but has been used most effectively with B. cenocepacia strain H111 to demonstrate the importance of quorum-sensing (QS) regulation in virulence (Huber et al., 2004) . As an alternative to mammalian animal models, we investigated the potential use of a C. elegans killing assay to study the role of TTS in B. cenocepacia. Using the pKNOCK vector system (Alexeyev, 1999), TTS knock-out mutants were constructed in two different strains of B. cenocepacia. A bscsN mutant of B. cenocepacia H111, analogous to the mutant used in a previous study (Tomich et al., 2003) , was constructed by cloning an internal region of the bcscN gene (encoding ATPase) into pKNOCK-Km. The region was PCR-amplified from B. cenocepacia using the oligonucleotide primers 59-ACCTCTA-GAAAGATGATCGACACGCCG-39 (forward primer containing an XbaI restriction site) and 59-ATCCTGCAGCTG-GTACTTCGCGATCAAC-39 (reverse primer containing a PstI restriction site), and cloned into pKNOCK-Km plasmid digested with XbaI and PstI. In addition, a bcscQR-virB1 knock-out mutant (bcscQ mutant) of B. cenocepacia C5424 (ET12 lineage) was constructed using the pKNOCK-Cm vector (Alexeyev, 1999) . A 2?5 kb SacII-XhoI fragment of the B. cenocepacia J2315 genome, comprising part of bcscQ, all of bcscR and part of virB1 (Glendinning et al., 2004) , was cloned into pKNOCK-Cm. The pKNOCK-Km-bcscN and pKNOCK-Cm-bcscQ constructs were subsequently introduced into B. cenocepacia H111 and B. cenocepacia C5424, respectively, by electroporation. Cells from 5 ml overnight broth cultures were harvested, washed twice in 10 % (v/v) glycerol and subsequently resuspended in 0?5 ml of the same solution. Bacterial suspension (100 ml) was mixed with DNA, transferred to 0?2 cm electrocuvettes, and subjected to a pulse of 2?5 kV (25 mF capacitance and 400 V resistance) using a GenePulser II apparatus (Bio-Rad). After electroporation and the addition of 0?9 ml L broth, cells were incubated at 37˚C for 2 h prior to plating onto media containing kanamycin (50 mg ml 21 ; for pKNOCK-Km-bcscN) or chloramphenicol (50 mg ml 21 ; for pKNOCK-Cm-bcscQ).
Genomic DNA was isolated from putative mutants using a Wizard Genomic DNA Purification kit (Promega). The position of the insertion was determined by cloning out the pKNOCK-Km/Cm regions into the KpnI site of pUC19 and sequencing using vector and internal primers. Sequencing confirmed that the pKNOCK construct had inserted into bcscN and bcscQ respectively. TTS mutant and wild-type strains were phenotypically similar with respect to growth rate in Luria broth and a series of 20 biochemical tests using the API ZYM kit (bioMérieux).
B. cenocepacia wild-type and two TTS mutant strains were tested in small-scale agar-plate assays for their ability to kill C. elegans, essentially using the method described by Köthe et al. (2003) . Bacterial lawns of the test strains and an E. coli control strain were prepared on nematode growth (NG) media to test for infective (slow-killing) effects. Small-scale assays were used in multi-segmented Petri dishes, in which each test was performed in an area of 1?5 cm 2 . After bacterial growth for 24 h at 37˚C, L4 larvae or adult worms (~50 and~10 for the bcscQ and bcscN mutants, respectively) were placed on the bacterial lawn. The plates were incubated at 23˚C and scored for live worms at intervals using a microscope set at 650 magnification. Results were obtained from three independent experiments (or two for the bcscN mutant), each experiment testing the ability of the wild-type strain, mutant strain and E. coli OP50 to kill C. elegans.
A comparison of the bcscN TTS mutant with B. cenocepacia H111 wild-type in the C. elegans slow-killing model of infection at time intervals of 24, 48 and 72 h post-infection indicated a significant difference (P <0?05) at the 48 and 72 h time-points (Fig. 1a) . When the bcscQ mutant was compared with wild-type B. cenocepacia C5424, at time intervals of 6, 18, 24 and 42 h, a significant difference (P <0?05) was only observed at the 18 h time-point (Fig. 1b) (Mahenthiralingam et al., 2000) . In our hands, B. cenocepacia C5424 was effective at killing C. elegans. The discrepancy may indicate that one or other version of strain C5424 has mutated.
Slow killing occurs over 2-3 days and involves the accumulation of bacteria in the intestinal lumen (Köthe et al., 2003) . Clearly, since mutation did not prevent host infection and killing, factors independent of the TTS system contribute to nematode killing by the BCC. However, our observations suggest that, given the right choice of strain and assay conditions, the C. elegans killing assays may provide a more accessible model for the study of defined mutations in the BCC TTS system and should facilitate efforts to resolve the role of this secretion system. C. elegans is well characterized genetically and many mutants are available for study (http://biosci.umn.edu/CGC/ CGChomepage.htm). It has been proposed as a useful model for studying host-pathogen interactions, and especially innate immune responses to infection (Gravato-Nobre & Hodgkin, 2005) . As yet, there are no known conditions in vitro that will trigger the expression of the BCC TTS system genes (Glendinning et al., 2004; Tomich et al., 2003) . Studies addressing the interaction between BCC and C. elegans may well provide us with a clearer idea of the role of TTS in the pathogenicity of these organisms.
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